The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 23, 2025
Filed:
Aug. 10, 2018
Applicants:
The Institute of Cancer Research:royal Cancer Hospital, London, GB;
The Royal Marsden Nhs Foundation Trust, London, GB;
Inventors:
Assignees:
The Institute of Cancer Research: Royal Cancer Hospital, London, GB;
The Royal Marsden NHS Foundation Trust, London, GB;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); G06F 18/2413 (2023.01); G16B 25/00 (2019.01); G16B 40/00 (2019.01); G16H 20/00 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/506 (2013.01); A61P 35/00 (2018.01); C07K 16/2863 (2013.01); G06F 18/24137 (2023.01); G16B 25/00 (2019.02); G16B 40/00 (2019.02); G16H 20/00 (2018.01); C07K 2317/21 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01);
Abstract
Materials and methods for stratifying and treating cancers and to methods of identifying/selecting patients for treatment of cancer with tyrosine kinase inhibitors are disclosed. Gene expression profiles, TP53 mutations and FGFR1 and PDGFRA expression used to identify/select/stratify the cancers and patients are also disclosed.